News
Facebook's data scientists manipulated the News Feeds of 689,003 users, filling them with either positive posts or negative posts or posts devoid of sentiment in order to see how it affected their ...
Whitney Ijem’s rating is based on a combination of strategic financial maneuvers and promising clinical development prospects for Passage Bio. The company has successfully offloaded three ...
Tessa Romero’s rating is based on the promising potential of Upstream Bio’s lead asset, verekitug, which is a monoclonal antibody targeting the TSLP receptor.
PHILADELPHIA, PA — Passage Bio, Inc. (Nasdaq: PASG) this week reported its third quarter financial results for 2024, highlighting substantial progress in its PBFT02 gene therapy program for ...
Positivity is Provocative — 3 Ways to Embrace Optimism in a Negative World How practicing gratitude, releasing negative people from your life and allowing yourself to dream again can reignite ...
SAB BIO, (“SAB BIO”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing human anti-thymocyte immunoglobulin (hIgG) for delaying the onset or ...
Facebook is a great way to connect with your followers, but sometimes our timelines and Facebook feed can get cluttered with bad news and negativity. So instead, share these nice quotes with your ...
- THN391 demonstrated effectiveness in protecting against vascular and neuronal degeneration - - Therini Bio plans to initiate a Phase 1/2a trial evaluating THN391 in DME in 2H24 - - The data was ...
SAN CARLOS, CA and FORT WORTH, TX / ACCESSWIRE / August 3, 2023 / CAGE Bio, Inc. (hereinafter "CAGE Bio") a biotechnology company focused on developing innovative drug therapies for localized ...
Annovis Bio Inc. ANVS is a clinical-stage pharmaceutical company focused on developing drugs for neurodegenerative diseases like Alzheimer’s disease, Parkinson’s disease, and dementia in Down ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results